TP53 and B-cell chronic lymphocytic leukemia: We also observed a significant acceleration of the clinical progression in exon 5–6 mutant TP53 gene CLL patients as compared with WTp53 CLL, whereas exon 7 mutants show a strong trend of faster clinical progression as compared with WTp53 CLL (Supplementary Figure 2).